Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 479

1.

Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction.

Hallén J, Buser P, Schwitter J, Petzelbauer P, Geudelin B, Fagerland MW, Jaffe AS, Atar D.

Am J Cardiol. 2009 Dec 1;104(11):1472-7. doi: 10.1016/j.amjcard.2009.07.019. Epub 2009 Oct 14.

PMID:
19932777
2.

Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.

Steen H, Futterer S, Merten C, Jünger C, Katus HA, Giannitsis E.

J Cardiovasc Magn Reson. 2007;9(5):749-58.

PMID:
17891611
3.

Predictive value of cardiac troponin-I compared to creatine kinase-myocardial band for the assessment of infarct size as measured by cardiac magnetic resonance.

Di Chiara A, Dall'Armellina E, Badano LP, Meduri S, Pezzutto N, Fioretti PM.

J Cardiovasc Med (Hagerstown). 2010 Aug;11(8):587-92. doi: 10.2459/JCM.0b013e3283383153.

PMID:
20588136
4.

Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial.

Atar D, Petzelbauer P, Schwitter J, Huber K, Rensing B, Kasprzak JD, Butter C, Grip L, Hansen PR, Süselbeck T, Clemmensen PM, Marin-Galiano M, Geudelin B, Buser PT; F.I.R.E. Investigators.

J Am Coll Cardiol. 2009 Feb 24;53(8):720-9. doi: 10.1016/j.jacc.2008.12.017.

6.

Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T.

Giannitsis E, Steen H, Kurz K, Ivandic B, Simon AC, Futterer S, Schild C, Isfort P, Jaffe AS, Katus HA.

J Am Coll Cardiol. 2008 Jan 22;51(3):307-14. doi: 10.1016/j.jacc.2007.09.041.

7.

Troponin T concentration 3 days after acute ST-elevation myocardial infarction predicts infarct size and cardiac function at 3 months.

Bøhmer E, Hoffmann P, Abdelnoor M, Seljeflot I, Halvorsen S.

Cardiology. 2009;113(3):207-12. doi: 10.1159/000201991. Epub 2009 Feb 14.

PMID:
19218804
8.

Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Haeck JD, Verouden NJ, Kuijt WJ, Koch KT, Van Straalen JP, Fischer J, Groenink M, Bilodeau L, Tijssen JG, Krucoff MW, De Winter RJ.

Am J Cardiol. 2010 Apr 15;105(8):1065-9. doi: 10.1016/j.amjcard.2009.12.003. Epub 2010 Feb 20.

PMID:
20381654
9.

Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function.

Steen H, Giannitsis E, Futterer S, Merten C, Juenger C, Katus HA.

J Am Coll Cardiol. 2006 Dec 5;48(11):2192-4. Epub 2006 Nov 9.

10.

Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".

Bruder O, Breuckmann F, Jensen C, Jochims M, Naber CK, Barkhausen J, Erbel R, Sabin GV; Herzinfarktverbund Essen.

Herz. 2008 Mar;33(2):136-42. doi: 10.1007/s00059-008-3102-8.

PMID:
18344033
11.

Prognostic significance of admission cardiac troponin T in patients treated successfully with direct percutaneous interventions for acute ST-segment elevation myocardial infarction.

Kurowski V, Hartmann F, Killermann DP, Giannitsis E, Wiegand UK, Frey N, Müller-Bardorff M, Richardt G, Katus HA.

Crit Care Med. 2002 Oct;30(10):2229-35.

PMID:
12394949
12.

Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention.

Hassan AK, Bergheanu SC, Hasan-Ali H, Liem SS, van der Laarse A, Wolterbeek R, Atsma DE, Schalij MJ, Jukema JW.

Am J Cardiol. 2009 Mar 15;103(6):779-84. doi: 10.1016/j.amjcard.2008.11.031. Epub 2009 Jan 24.

PMID:
19268731
13.

Relationship between blood viscosity and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Cecchi E, Liotta AA, Gori AM, Valente S, Giglioli C, Lazzeri C, Sofi F, Gensini GF, Abbate R, Mannini L.

Int J Cardiol. 2009 May 15;134(2):189-94. doi: 10.1016/j.ijcard.2008.01.039. Epub 2008 May 20.

PMID:
18495262
14.

Prognostic value of C-reactive protein and cardiac troponin I in primary percutaneous interventions for ST-elevation myocardial infarction.

Ohlmann P, Jaquemin L, Morel O, El Behlgiti R, Faure A, Michotey MO, Beranger N, Roul G, Schneider F, Bareiss P, Monassier JP.

Am Heart J. 2006 Dec;152(6):1161-7.

PMID:
17161070
16.

Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction.

Sörensson P, Saleh N, Bouvier F, Böhm F, Settergren M, Caidahl K, Tornvall P, Arheden H, Rydén L, Pernow J.

Heart. 2010 Nov;96(21):1710-5. doi: 10.1136/hrt.2010.199430.

PMID:
20956486
17.

Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance.

Francone M, Bucciarelli-Ducci C, Carbone I, Canali E, Scardala R, Calabrese FA, Sardella G, Mancone M, Catalano C, Fedele F, Passariello R, Bogaert J, Agati L.

J Am Coll Cardiol. 2009 Dec 1;54(23):2145-53. doi: 10.1016/j.jacc.2009.08.024.

18.

HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction.

Andrassy M, Volz HC, Riedle N, Gitsioudis G, Seidel C, Laohachewin D, Zankl AR, Kaya Z, Bierhaus A, Giannitsis E, Katus HA, Korosoglou G.

J Intern Med. 2011 Sep;270(3):245-53. doi: 10.1111/j.1365-2796.2011.02369.x. Epub 2011 Mar 28.

19.

Relation of circulating MicroRNA-133a concentrations with myocardial damage and clinical prognosis in ST-elevation myocardial infarction.

Eitel I, Adams V, Dieterich P, Fuernau G, de Waha S, Desch S, Schuler G, Thiele H.

Am Heart J. 2012 Nov;164(5):706-14. doi: 10.1016/j.ahj.2012.08.004.

PMID:
23137501
20.

Release of necrosis markers and cardiovascular magnetic resonance-derived microvascular perfusion in reperfused ST-elevation myocardial infarction.

Husser O, Bodi V, Sanchis J, Nunez J, Mainar L, Rumiz E, Lopez-Lereu MP, Monmeneu JV, Forteza MJ, Oltra R, Riegger GA, Chorro FJ, Llacer A.

Thromb Res. 2009 Nov;124(5):592-600. doi: 10.1016/j.thromres.2009.05.015. Epub 2009 Jun 21.

PMID:
19540571

Supplemental Content

Support Center